The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.

Kate Winslet recently spoke about how life changed for her after the award-winning movie “Titanic” hit the screens.

Novo Nordisk's ADRs rose 8% higher to $51.99 in post-market trading on volume that topped 1.2 million ADRs. The stock ended the day's market session little changed at $48.10. The approval makes Wegovy ...

The Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's blockbuster weight-loss drug ...

U.S. regulators approved the first GLP-1 weight-loss pill—a tablet formulation of Novo Nordisk’s Ozempic and Wegovy—ushering ...

The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to ...

Investing.com -- Novo Nordisk A/S (NYSE:NVO) stock jumped nearly 8% in after-hours trading on Monday after the U.S. Food and Drug Administration approved the company’s Wegovy pill as the first oral ...

Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday, giving ​the Danish drugmaker a leg up in the ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the Wegovy ® pill (once-daily oral semaglutide 2 ...

The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.